Osteosarcoma overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:
{{Osteosarcoma}}
{{Osteosarcoma}}
==Overview==
==Overview==
Bone cancer is a malignant (cancerous) tumor of the bone that destroys normal bone tissue. Osteosarcoma is the most common type of malignant bone cancer, accounting for 35% of primary bone malignancies. It is a malignant tumor that is characterized by the direct formation of bone or osteoid tissue by the tumor cells. Malignant tumors that begin in bone tissue are called primary bone cancer. Osteosarcoma may be classified according to the [[World Health Organization]]’s histologic classification of bone tumors into three groups. The osteosarcomas may be localized at the end of the long bones (commonly in the [[metaphysis]]). Most often it affects the upper end of the [[tibia]], [[humerus]], or lower end of the [[femur]]. On [[gross pathology]], areas of bone formation, [[hemorrhage]], [[fibrosis]], and cystic degeneration on cut surface are characteristic findings of osteosarcoma. On microscopic [[histopathological]] analysis, presence of [[osteoid]] within the tumor, [[pleomorphic]] cells, [[anaplastic]] cells, and atypical [[mitoses]] are characteristic findings of osteosarcoma. There are no established causes for osteosarcoma. The common risk factors in the development of osteosarcoma are [[radiation]] to bones, [[alkylating antineoplastic agents]], [[Paget disease]], multiple hereditary [[osteochondromas]], [[fibrous dysplasia]], [[Bloom syndrome]], [[Rothmund-Thomson syndrome]], and [[Li-Fraumeni syndrome]]. Common complications of osteosarcoma include pathologic fracture and [[metastasis]]. The most common symptoms of osteosarcoma include [[bone pain]] that may be worse at night, [[swelling]], and redness at the site of the tumor. On x-ray, osteosarcoma is characterized by [[medullary]] and [[Cortical bone|cortical]] bone destruction, [[periosteal reaction]], tumor matrix [[calcification]], and soft tissue mass. On MRI, osteosarcoma is characterized by intermediate intensity of soft tissue and low signal intensity of [[ossified]] components on T1. High signal intensity of soft tissue and low signal intensity of ossified components on [[Magnetic resonance imaging|T2]]. The predominant therapy for osteosarcoma is [[neoadjuvant]] [[chemotherapy]] ([[chemotherapy]] given before surgery) followed by surgical resection.  The most common drugs used to treat osteosarcoma are [[cisplatin]], [[doxorubicin]] and high-dose [[methotrexate]].
[[Bone cancer]] is a [[malignant]] ([[cancerous]]) [[tumor]] of the [[bone]] that destroys normal [[bone]] tissue. [[Osteosarcoma]] is the most common type of [[malignant]] [[bone cancer]], accounting for 35% of primary bone [[malignancies]]. It is a [[Malignant tumors|malignant tumor]] that is characterized by the direct formation of bone or [[osteoid]] tissue by the [[Tumor cell|tumor]] cells. [[Malignant tumors]] that begin in bone [[tissue]] are called primary bone cancer. [[Osteosarcoma]] may be classified according to the [[World Health Organization]]’s histologic classification of [[bone tumors]] into three groups. The [[Osteosarcoma|osteosarcomas]] may be localized at the end of the [[long bones]] (commonly in the [[metaphysis]]). Most often it affects the upper end of the [[tibia]], [[humerus]], or lower end of the [[femur]]. On [[gross pathology]], areas of bone formation, [[hemorrhage]], [[fibrosis]], and [[cystic]] degeneration on cut surface are characteristic findings of [[osteosarcoma]]. On microscopic [[histopathological]] analysis, presence of [[osteoid]] within the tumor, [[pleomorphic]] cells, [[anaplastic]] cells, and atypical [[mitoses]] are characteristic findings of [[osteosarcoma]]. There are no established causes for [[osteosarcoma]]. The common risk factors in the development of [[osteosarcoma]] are [[radiation]] to bones, [[alkylating antineoplastic agents]], [[Paget disease]], multiple hereditary [[osteochondromas]], [[fibrous dysplasia]], [[Bloom syndrome]], [[Rothmund-Thomson syndrome]], and [[Li-Fraumeni syndrome]]. Common complications of osteosarcoma include pathologic [[fracture]] and [[metastasis]]. The most common symptoms of [[osteosarcoma]] include [[bone pain]] that may be worse at night, [[swelling]], and redness at the site of the [[tumor]]. On [[X-rays|x-ray]], [[osteosarcoma]] is characterized by [[medullary]] and [[Cortical bone|cortical]] bone destruction, [[periosteal reaction]], tumor [[matrix]] [[calcification]], and soft tissue [[mass]]. On [[Magnetic resonance imaging|MRI]], [[osteosarcoma]] is characterized by intermediate intensity of soft tissue and low signal intensity of [[ossified]] components on [[T1]]. High signal intensity of soft tissue and low signal intensity of ossified components on [[Magnetic resonance imaging|T2]]. The predominant therapy for [[osteosarcoma]] is [[neoadjuvant]] [[chemotherapy]] ([[chemotherapy]] given before [[surgery]]) followed by surgical [[resection]].  The most common drugs used to treat osteosarcoma are [[cisplatin]], [[doxorubicin]] and high-dose [[methotrexate]].


== Historical perspective ==
== Historical perspective ==

Revision as of 13:16, 10 October 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2].

Osteosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Osteosarcoma overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteosarcoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteosarcoma overview

CDC on Osteosarcoma overview

Osteosarcoma overview in the news

Blogs on Osteosarcoma overview

Directions to Hospitals Treating Osteosarcoma

Risk calculators and risk factors for Osteosarcoma overview

Overview

Bone cancer is a malignant (cancerous) tumor of the bone that destroys normal bone tissue. Osteosarcoma is the most common type of malignant bone cancer, accounting for 35% of primary bone malignancies. It is a malignant tumor that is characterized by the direct formation of bone or osteoid tissue by the tumor cells. Malignant tumors that begin in bone tissue are called primary bone cancer. Osteosarcoma may be classified according to the World Health Organization’s histologic classification of bone tumors into three groups. The osteosarcomas may be localized at the end of the long bones (commonly in the metaphysis). Most often it affects the upper end of the tibia, humerus, or lower end of the femur. On gross pathology, areas of bone formation, hemorrhage, fibrosis, and cystic degeneration on cut surface are characteristic findings of osteosarcoma. On microscopic histopathological analysis, presence of osteoid within the tumor, pleomorphic cells, anaplastic cells, and atypical mitoses are characteristic findings of osteosarcoma. There are no established causes for osteosarcoma. The common risk factors in the development of osteosarcoma are radiation to bones, alkylating antineoplastic agents, Paget disease, multiple hereditary osteochondromas, fibrous dysplasia, Bloom syndrome, Rothmund-Thomson syndrome, and Li-Fraumeni syndrome. Common complications of osteosarcoma include pathologic fracture and metastasis. The most common symptoms of osteosarcoma include bone pain that may be worse at night, swelling, and redness at the site of the tumor. On x-ray, osteosarcoma is characterized by medullary and cortical bone destruction, periosteal reaction, tumor matrix calcification, and soft tissue mass. On MRI, osteosarcoma is characterized by intermediate intensity of soft tissue and low signal intensity of ossified components on T1. High signal intensity of soft tissue and low signal intensity of ossified components on T2. The predominant therapy for osteosarcoma is neoadjuvant chemotherapy (chemotherapy given before surgery) followed by surgical resection. The most common drugs used to treat osteosarcoma are cisplatin, doxorubicin and high-dose methotrexate.

Historical perspective

Osteosarcoma is known as the most common bone malignant tumor. Osteosarcoma is an ancient disease and is not completely understood, yet. Nobody knows when and who discovered Osteosarcoma, but recent Paleontology discoveries revealed that Osteosarcoma has a long story in planet earth. Resent discoverers in Germany revealed a 240 million-year-old highly malignant tumor in the fossilized leg bone of a stem turtle. Its been found that osteosarcoma is the earliest case of human cancer which was found on the 1.7 million-year-old fossil of an early ancestor of mankind in Swartkrans cave in South Africa. In 1990, a thousand-year-old mummy of a woman in her mid-30s of age had with a malignant tumor in her upper-left arm which that mass had grown so large that it might burst through her skin while she was still alive.

Classification

Osteosarcoma (OS) is a rare bone cancer which affects both adolescents and young adults. Osteosarcoma was classified as primary and secondary. Later the the World Health Organization sub-typed as intramedullry/central and surface osteosarcoma with a number of sub-types under each group.

Pathophysiology

Traditionally, our knowledge about osteosarcoma has been mostly anatomical but it should be noted that it arises most commonly in the metaphyseal region of long bones, within the medullary cavity, then it involves the bone cortex; consequently a pseudocapsule forms around the penetrating tumor. Osteosarcoma is characterised as a highly cellular tumor consisted of: pleomorphic spindle-shaped cells responsible for the producing an osteoid matrix. However, recent developments in the field of medical sciences and the molecular biology have provided huge insights regarding the molecular pathogenesis of osteosarcoma.

Causes

There are no established causes for osteosarcoma. However, some studies show that an increased level of c-fos proto-oncogene expression can lead to osteosarcoma.

Differential Diagnosis

Osteosarcoma must be differentiated from other diseases such as: any type of bone lesions caused by infection and/or tumors. Features such as the eccentric location of the tumor in the metaphyseal portion of the bone and the skeletal location help to distinguish osteosarcoma from Ewing sarcoma. Bone metastases from other primary tumours, less frequent in the young than in adult patients, should also be considered.

Epidemiology and Demographics

Osteosarcoma is the most common nonhematologic primary malignant bone neoplasm causing 35% of primary bone malignancies and occurs at any age, it usually affects patients in the second and third decade of life with a peak incidence between 13 and 16 years of age. It is the 8th leading cancer in children under age 15, comprising 2.4% of all malignancies in pediatric patients and about 20% of all primary bone cancers. The overall incidence of osteosarcoma in U.S. population under 24 years of age are estimated at 0.44 cases for 100,000 individuals. Osteosarcoma is slightly more common in males than in females. Primary osteosarcoma typically occurs in young patients (10-20 years) with 75% occurring before the age of 20. Secondary osteosarcoma occurs in elderly patients.

Risk Factors

Common risk factors in the development of osteosarcoma are radiation to bones, alkylating antineoplastic agents, Paget disease, multiple hereditary osteochondromas, fibrous dysplasia, Bloom syndrome,Rothmund-Thomson syndrome, and Li-Fraumeni syndrome.


Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for osteosarcoma.

Natural History, Complications and Prognosis

Common complications of osteosarcoma include pathologic fracture and metastasis. Pre-treatment factors that influence outcome of the osteosarcoma are primary tumor site, size of the primary tumor, and site of metastasis. After administration of preoperative chemotherapy, factors that influence outcome of the osteosarcoma are adequacy of tumor resection and necrosis following induction or neoadjuvant chemotherapy. The 5 year survival rate of osteosarcoma after adequate therapy is approximately 60-80%.


Diagnosis

Staging

According to the American Joint Committee on Cancer (AJCC), there are four stages of osteosarcoma based on the size of primary tumor, metastasis, involvement of lymph nodes, and grade of the tumor. For the purpose of treatment, there are only two stages of high-grade osteosarcoma: localized osteosarcoma and metastatic osteosarcoma.

History and Symptoms

The most common symptoms of osteosarcoma include bone pain that may worse at night, swelling, and redness at the site of the tumor. The affected bone is not as strong as normal bones and may fracture with minor trauma (a pathological fracture).


Physical Examination

Physical examination findings will depend on the location of the osteosarcoma. Common physical examination findings of osteosarcoma are localized swelling and tenderness at the site of the tumor.

Laboratory Findings

Laboratory tests for osteosarcoma include complete blood count (CBC), serum alkaline phosphatase and lactate dehydrogenase.

Biopsy

Biopsy of osteosarcoma is important for confirming the diagnosis and for determining the histologic subtype.[1] Biopsy may be performed percutaneously with either a fine-needle, or a wide-bore needle, or through a formal incision.

X Ray

On x-ray, osteosarcoma is characterized by medullary and cortical bone destruction, periosteal reaction, tumor matrix calcification, and soft tissue mass.

CT

CT scan in osteosarcoma may be helpful in biopsy and staging. CT scan adds little to plain radiography and MRI in direct assessment of the tumor.

MRI

On MRI, osteosarcoma is characterized by intermediate intensity of soft tissue and low signal intensity of ossified components on T1. High signal intensity of soft tissue and low signal intensity of ossified components on T2. Considerable contrast enhancement of solid components on T1 contrast.

Other Imaging Findings

Bone scan in osteosarcoma is used to observe abnormal areas of bone and metastasis.

Other Diagnostic Studies

Bone scan in osteosarcoma is used to observe abnormal areas of bone and metastasis.

Treatment

Medical Therapy

The predominant therapy for osteosarcoma is neoadjuvant chemotherapy (chemotherapy given before surgery) followed by surgical resection. The most common drugs used to treat osteosarcoma are cisplatin, doxorubicin and high-dose methotrexate. Ifosfamide can be used as an adjuvant treatment if the necrosis rate is low. Samarium is a radioactive drug that targets areas where bone cells are growing, such as tumor cells in the bone. It helps relieve bone pain.

Surgery

The mainstay of therapy for osteosarcoma is surgical resection. Rather than using the standard staging system, a simpler system is often used when planning treatment for osteosarcoma. This system divides osteosarcomas into 2 groups: localized osteosarcoma and metastatic osteosarcoma.

References

Template:WH Template:WS